Suppr超能文献

旨在提高阻塞性睡眠呼吸暂停成年人持续气道正压通气机使用情况的教育、支持及行为干预措施。

Educational, supportive and behavioural interventions to improve usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea.

作者信息

Askland Kathleen, Wright Lauren, Wozniak Dariusz R, Emmanuel Talia, Caston Jessica, Smith Ian

机构信息

Waypoint Centre for Mental Health Care, Waypoint Research Institute, Penetanguishene, Canada.

AstraZeneca Canada Inc., Mississauga, Ontario, Canada.

出版信息

Cochrane Database Syst Rev. 2020 Apr 7;4(4):CD007736. doi: 10.1002/14651858.CD007736.pub3.

Abstract

BACKGROUND

Although highly effective in the treatment of obstructive sleep apnoea (OSA), continuous positive airway pressure (CPAP) is not universally accepted by users. Educational, supportive and behavioural interventions may help people with OSA initiate and maintain regular and continued use of CPAP.

OBJECTIVES

To assess the effectiveness of educational, supportive, behavioural, or mixed (combination of two or more intervention types) strategies that aim to encourage adults who have been prescribed CPAP to use their devices.

SEARCH METHODS

Searches were conducted on the Cochrane Airways Group Specialised Register of trials. Searches are current to 29 April 2019.

SELECTION CRITERIA

We included randomised controlled trials (RCTs) that assessed intervention(s) designed to inform participants about CPAP/OSA, to support them in using CPAP, or to modify their behaviour to increase use of CPAP devices.

DATA COLLECTION AND ANALYSIS

We assessed studies to determine their suitability for inclusion in the review. Data were extracted independently and were entered into RevMan for analysis. 'Risk of bias' assessments were performed, using the updated 'Risk of bias 2' tool, for the primary outcome, CPAP usage. Study-level 'Risk of bias' assessments were performed using the original 'Risk of bias' tool. GRADE assessment was performed using GRADEpro.

MAIN RESULTS

Forty-one studies (9005 participants) are included in this review; 16 of these studies are newly identified with updated searches. Baseline Epworth Sleepiness Scale (ESS) scores indicate that most participants suffered from excessive daytime sleepiness. The majority of recruited participants had not used CPAP previously. When examining risk of bias for the primary outcome of hourly machine usage/night, 58.3% studies have high overall risk (24/41 studies), 39.0% have some concerns (16/41 studies), and 2.4% have low overall risk (1/41 studies). We are uncertain whether educational interventions improve device usage, as the certainty of evidence was assessed as very low. We were unable to perform meta-analyses for number of withdrawals and symptom scores due to high study heterogeneity. Supportive interventions probably increase device usage by 0.70 hours/night (95% confidence interval (CI) 0.36 to 1.05, N = 1426, 13 studies, moderate-certainty evidence), and low-certainty evidence indicates that the number of participants who used their devices ≥ 4 hours/night may increase from 601 to 717 per 1000 (odds ratio (OR), 1.68, 95% CI 1.08 to 2.60, N = 376, 2 studies). However, the number of withdrawals may also increase from 136 to 167 per 1000 (OR 1.27, 95% CI 0.97 to 1.66, N = 1702, 11 studies, low-certainty evidence). Participants may experience small improvements in symptoms (ESS score -0.32 points, 95% CI -1.19 to 0.56, N = 470, 5 studies, low-certainty evidence), and we are uncertain whether quality of life improves with supportive interventions, as the certainty of evidence was assessed as very low. When compared with usual care, behavioural interventions produce a clinically-meaningful increase in device usage by 1.31 hours/night (95% CI 0.95 to 1.66, N = 578, 8 studies, high-certainty evidence), probably increase the number of participants who used their machines ≥ 4 hours/night from 371 to 501 per 1000 (OR 1.70, 95% CI 1.20 to 2.41, N = 549, 6 studies, high-certainty evidence), and reduce the number of study withdrawals from 146 to 101 per 1000 (OR 0.66, 95% CI 0.44 to 0.98, N = 939, 10 studies, high-certainty evidence). Behavioural interventions may reduce symptoms (ESS score -2.42 points, 95% CI -4.27 to -0.57, N = 272, 5 studies, low-certainty evidence), but probably have no effect on quality of life (Functional Outcomes of Sleep Questionnaire (FOSQ), standardised mean difference (SMD) 0.00, 0.95% CI -0.26 to 0.26, N = 228, 3 studies, moderate-certainty evidence). We are uncertain whether behavioural interventions improve apnoea hypopnoea index (AHI), as the certainty of evidence was assessed as very low. We are uncertain if mixed interventions improve device usage, increase the number of participants using their machines ≥ 4 hours/night, reduce study withdrawals, improve quality of life, or reduce anxiety symptoms, as the certainty of evidence for these outcomes was assessed to be very low. Symptom scores via the ESS could not be measured due to considerable heterogeneity between studies.

AUTHORS' CONCLUSIONS: In CPAP-naïve people with OSA, high-certainty evidence indicates that behavioural interventions yield a clinically-significant increase in hourly device usage when compared with usual care. Moderate certainty evidence shows that supportive interventions increase usage modestly. Very low-certainty evidence shows that educational and mixed interventions may modestly increase CPAP usage. The impact of improved CPAP usage on daytime sleepiness, quality of life, and mood and anxiety scores remains unclear since these outcomes were not assessed in the majority of included studies. Studies addressing the choice of interventions that best match individual patient needs and therefore result in the most successful and cost-effective therapy are needed.

摘要

背景

持续气道正压通气(CPAP)治疗阻塞性睡眠呼吸暂停(OSA)虽疗效显著,但并非被所有使用者普遍接受。教育、支持和行为干预可能有助于OSA患者开始并持续规律使用CPAP。

目的

评估旨在鼓励已开具CPAP处方的成年人使用该设备的教育、支持、行为或混合(两种或更多干预类型的组合)策略的有效性。

检索方法

在Cochrane气道组专业试验注册库中进行检索。检索截至2019年4月29日。

入选标准

我们纳入了随机对照试验(RCT),这些试验评估了旨在让参与者了解CPAP/OSA、支持他们使用CPAP或改变其行为以增加CPAP设备使用的干预措施。

数据收集与分析

我们评估研究以确定其是否适合纳入本综述。数据由独立人员提取并录入RevMan进行分析。使用更新后的“偏倚风险2”工具对主要结局CPAP使用情况进行“偏倚风险”评估。使用原始的“偏倚风险”工具进行研究层面的“偏倚风险”评估。使用GRADEpro进行GRADE评估。

主要结果

本综述纳入了41项研究(9005名参与者);其中16项研究是通过更新检索新发现的。基线爱泼沃斯嗜睡量表(ESS)评分表明,大多数参与者存在日间过度嗜睡。大多数招募的参与者此前未使用过CPAP。在检查每小时机器使用/晚这一主要结局的偏倚风险时,58.3%的研究总体风险高(24/41项研究),39.0%存在一些担忧(16/41项研究),2.4%总体风险低(1/41项研究)。由于证据确定性被评估为极低,我们不确定教育干预是否能改善设备使用情况。由于研究异质性高,我们无法对退出人数和症状评分进行Meta分析。支持性干预可能使设备使用量每晚增加0.70小时(95%置信区间(CI)0.36至1.05,N = 1426,13项研究,中等确定性证据),低确定性证据表明,每晚使用设备≥4小时的参与者人数可能从每1000人601人增加到717人(比值比(OR)1.68,95%CI 1.08至2.60,N = 376,2项研究)。然而,退出人数也可能从每1000人136人增加到167人(OR 1.27,95%CI 0.97至1.66,N = 1702,11项研究,低确定性证据)。参与者的症状可能有小幅改善(ESS评分 -0.32分,95%CI -1.19至0.56,N = 470,5项研究,低确定性证据),由于证据确定性被评估为极低,我们不确定支持性干预是否能改善生活质量。与常规护理相比,行为干预使设备使用量每晚有临床意义地增加1.31小时(95%CI 0.95至1.66,N = 578,8项研究,高确定性证据),可能使每晚使用机器≥4小时的参与者人数从每1000人371人增加到501人(OR 1.70,95%CI 1.20至2.41,N = 549,6项研究,高确定性证据),并使研究退出人数从每1000人146人减少到101人(OR 0.66,95%CI 0.44至0.98,N = 939,10项研究,高确定性证据)。行为干预可能减轻症状(ESS评分 -2.42分,95%CI -4.27至 -0.57,N = 272,5项研究,低确定性证据),但可能对生活质量无影响(睡眠功能结局问卷(FOSQ),标准化均数差(SMD)0.00,95%CI -0.26至0.26,N = 228,3项研究,中等确定性证据)。由于证据确定性被评估为极低,我们不确定行为干预是否能改善呼吸暂停低通气指数(AHI)。由于这些结局的证据确定性被评估为极低,我们不确定混合干预是否能改善设备使用情况、增加每晚使用机器≥4小时的参与者人数、减少研究退出人数、改善生活质量或减轻焦虑症状。由于研究之间存在相当大的异质性,无法通过ESS测量症状评分。

作者结论

在未使用过CPAP的OSA患者中,高确定性证据表明,与常规护理相比,行为干预使每小时设备使用量有临床显著增加。中等确定性证据表明,支持性干预适度增加使用量。极低确定性证据表明,教育和混合干预可能适度增加CPAP使用量。由于大多数纳入研究未评估这些结局,CPAP使用量改善对日间嗜睡、生活质量以及情绪和焦虑评分的影响仍不清楚。需要开展研究以确定最符合个体患者需求从而带来最成功且最具成本效益治疗的干预措施选择。

相似文献

6
Positional therapy for obstructive sleep apnoea.阻塞性睡眠呼吸暂停的体位治疗
Cochrane Database Syst Rev. 2019 May 1;5(5):CD010990. doi: 10.1002/14651858.CD010990.pub2.
8
Non-invasive positive pressure ventilation for central sleep apnoea in adults.成人中枢性睡眠呼吸暂停的无创正压通气。
Cochrane Database Syst Rev. 2022 Oct 24;10(10):CD012889. doi: 10.1002/14651858.CD012889.pub2.

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验